Cite
Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
MLA
Marcos González, et al. Genomic Mutation Profile in Progressive Chronic Lymphocytic Leukemia Patients Prior to First-Line Chemoimmunotherapy with FCR and Rituximab Maintenance (REM). Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1b7c900b119d468b1a8ae042f0c38ee7&authtype=sso&custid=ns315887.
APA
Marcos González, Eduardo Anguita, Ernesto Pérez-Persona, Belén Navarro-Matilla, Sara Nova-Gurumeta, Lucrecia Yáñez, Valle Recasens, Eva González-Barca, Rosa Collado, Javier López-Jiménez, Javier de la Serna, Sagrario Gómez, Raul Cordoba, Belen Fernandez-Cuevas, M.Angeles Andreu, Margarita Sánchez-Beato, María del Carmen Marquetti Fernández, M. Dolores García-Malo, Francisco Javier Peñalver, … Julia González-Rincón. (2021). Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM).
Chicago
Marcos González, Eduardo Anguita, Ernesto Pérez-Persona, Belén Navarro-Matilla, Sara Nova-Gurumeta, Lucrecia Yáñez, Valle Recasens, et al. 2021. “Genomic Mutation Profile in Progressive Chronic Lymphocytic Leukemia Patients Prior to First-Line Chemoimmunotherapy with FCR and Rituximab Maintenance (REM),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1b7c900b119d468b1a8ae042f0c38ee7&authtype=sso&custid=ns315887.